Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

Prostate

Volumn 42, Issue 4, 2000, Pages 295-303

  Sun, Baodong ^a,b   Halmos, Gabor ^a,b   Schally, Andrew V ^a,b   Wang, Xiaofei ^c   Martinez, Miriam ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Bombesin receptor; Cancer therapy; Peptide analogs; Prostate cancer; Receptor binding assay; RT PCR

Indexed keywords

BOMBESIN RECEPTOR; GASTRIN RELEASING PEPTIDE; MESSENGER RNA; NEUROMEDIN B; RECEPTOR PROTEIN;

ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; HUMAN; HUMAN TISSUE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR BINDING; TUMOR GROWTH;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BINDING, COMPETITIVE; BOMBESIN; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOLIGAND ASSAY; RECEPTORS, BOMBESIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033953894     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000301)42:4<295::AID-PROS7>3.0.CO;2-B     Document Type: Article

References (40)

1. Raghavan D, Rogers J. Update in the management of prostate cancer. Med J Aust 1990;152:419-426.
2. Schally AV, Comaru-Schally AM. Hypothalamic and other peptide hormones. In: Holland JF, Frei E III, Bast RC Jr, Kufe DE, Morton DL, Weichselbaum RR, editors. Cancer medicine, 4th ed. Baltimore: Williams & Wilkins; 1997. p 1067-1085.
3. Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 1989;63:1714-1720.
4. Shimoda J. Effects of bombesin and its antibody on growth of human prostatic carcinoma cell lines. Jpn J Urol 1992;83:1459-1468.
5. Hoosein NM, Logothetis CJ, Chung LW. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 1993;149:1209-1213.
6. Aprikian AG, Han K, Guy L, Landry F, Begin LR, Chevalier S. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer. Prostate [Suppl] 1998;8:52-61.
7. 4) bombesin by tumor cells. Prostate 1994;25:29-38.
8. Aprikian AG, Han K, Chevalier S, Bazinet M, Viallet J. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J Mol Endocrinol 1996;16:297-306.
9. 2 or its derivatives. Proc Natl Acad Sci USA 1994;91:12664-12668.
10. Cai R-Z, Radulovic S, Pinski J, Nagy A, Redding TW, Olsen D, Schally AV. Pseudononapeptide bombesin antagonists containing C-terminal Trp or D-Tpi. Peptides 1992;13:267-271.
11. 11 substance P, a potent bombesin antagonist in murine swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro. Proc Natl Acad Sci USA 1988;85:1859-1863.
12. Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis I, Cuttitta F, Mulshine JL, Moody TW. (Psi 13,14) bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res 1991;51:1798-1802.
13. Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, Groot K, Schally AV. LH-RH antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate 1997;32:164-172.
14. Jungwirth A, Pinski J, Galvan G, Halmos, G, Szepeshazi K, Cai RZ, Groot K, Vadillo-Buenfil M, Schally AV. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur J Cancer 1997;33:1141-1148.
15. Qin Y, Halmos G, Cai RZ, Szoke B, Ertl T, Schally AV. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors. J Cancer Res Clin Oncol 1994;200:519-528.
16. Radulovic S, Schally AV, Reile H, Halmos G, Szepeshazi K, Groot K, Milovanovic S, Miller G, Yano T. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol 1994;33:693-701.
17. Halmos G, Schally AV. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc Natl Acad Sci USA 1997;94:956-960.
18. Qin Y, Ertl T, Cai RZ, Horvath JE, Groot K, Schally AV. Antagonists of bombesin/gastrin releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. Int J Cancer. 1995;63:257-262.
19. Yano T, Pinski J, Groot K, Schally AV. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992;52:4545-4547.
20. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res 1994;54:5895-5901.
21. Nagy A, Armatis P, Cai R-Z, Szepeshazi K, Halmos G, Schally AV. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci USA 1997;94:652-656.
22. Halmos G, Wittliff JL, Schally AV. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res 1995;55:280-287.
23. Frankel A, Tsao M-S, Viallet J. Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells. Cancer Res 1994;54:1613-1616.
24. Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA, Battey JF. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem 1993;268:5979-5984.
25. Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, Jensen RT. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem 1997;272:26062-26071.
26. Gordon AW, Pegues JC, Johnson GR, Kannan B, Auesperg N, Stromberg K. mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells. Cancer Lett 1995;89:63-71.
27. McPherson GA. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods 1985;14:213-228.
28. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 1999;59:1152-1159.
29. Bartholdi MF, Wu JM, Pu H, Troncoso P, Eden PA, Feldman RI. In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. Int J Cancer 1998; 79:82-90.
30. Feldman RI, Bartholdi MF, Wu JM. Bombesin-like peptide receptor subtypes promote mitogenesis which requires persistent receptor signaling. Mol Pharmacol 1996;50:1346-1354.
31. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985;316:823-826.
32. Avis I, Jett M, Kasprzyk PG, Cuttitta F, Treston AM, Maneckjee R, Mulshine JL. Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinog 1993;8:214-220.
33. Nelson J, Donnelly M, Walker B, Gray J, Shaw C, Murphy RF. Bombesin stimulates proliferation of human breast cancer cells in culture. Br J Cancer 1991;63:933-936.
34. Frucht H, Gazdar AF, Park JA, Oie H, Jensen RT. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992;52:1114-1122.
35. Siegfried JM, Guentert PJ, Gaither AL. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogs. Anat Rec 1993;236:241-247.
36. DeMichele MA, Gaither Davis AL, Hunt JD, Landreneau RJ, Siegfried JM. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994;11:66-74.
37. Koh SM, Leyton J, Moody TW. Bombesin activates MAP kinase in non-small cell lung cancer cells. Peptides 1999;20:121-126.
38. Fathi Z, Way JW, Corjay MH, Viallet J, Sausville EA, Battey JF. Bombesin receptor structure and expression in human lung carcinoma cell lines. J Cell Biochem [Suppl] 1996;24:237-246.
39. Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH, Jensen RT. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3. J Biol Chem 1998;273:13613-13624.
40. Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993;71:3952-3965.